menu
    • menu

    Company profile for Apollo Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Apollo Therapeutics is rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. We foster deep relationships with top scientists and inventors at world leading institutions to identify programs with strong biological hypotheses and the potential to become meaningful new treatment options. Our team combines drug development ‘architects’ and deep subject matter...
    Apollo Therapeutics is rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. We foster deep relationships with top scientists and inventors at world leading institutions to identify programs with strong biological hypotheses and the potential to become meaningful new treatment options. Our team combines drug development ‘architects’ and deep subject matter experts who together are building an expansive and de-risked pipeline in oncology, major inflammatory disorders and rare disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apollo Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Stevenage, Herefordshire, United Kingdom
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://apollotherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apollo-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apollo $15M Bet on IL-18 Antibody Pays Off with Ph 2 Eczema Win
    Apollo $15M Bet on IL-18 Antibody Pays Off with Ph 2 Eczema Win

    16 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/apollos-15m-bet-il-18-antibody-pays-phase-2-eczema-win

    FIERCE BIOTECH
    16 Sep 2025
    Share Share
    Apollo Therapeutics Signs Exclusive License for FGF21/GLP-1 Agonist
    Apollo Therapeutics Signs Exclusive License for FGF21/GLP-1 Agonist

    12 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241112468150/en

    BUSINESSWIRE
    12 Nov 2024
    Share Share
    Apollo Therapeutics Partners With Oxford For Drug Discovery And Dev
    Apollo Therapeutics Partners With Oxford For Drug Discovery And Dev

    21 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240721769962/en

    BUSINESSWIRE
    21 Jul 2024
    Share Share
    Apollo Therapeutics Announces Second Close of Series C Financing
    Apollo Therapeutics Announces Second Close of Series C Financing

    02 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240101511349/en

    BUSINESSWIRE
    02 Jan 2024
    Share Share
    Apollo Closes $226.5 Million Series C Financing Led by Patient Square Capital
    Apollo Closes $226.5 Million Series C Financing Led by Patient Square Capital

    06 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230906788078/en

    BUSINESSWIRE
    06 Sep 2023
    Share Share
    ICR announces collaboration with Apollo to develop novel cancer drugs
    ICR announces collaboration with Apollo to develop novel cancer drugs

    28 Nov 2022

    // PRESS RELEASE

    https://www.icr.ac.uk/news-archive/icr-announces-new-strategic-collaboration-with-apollo-therapeutics-to-develop-novel-cancer-drugs

    PRESS RELEASE
    28 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search